Adis Journals
Browse

A Multicenter, Retrospective Study (RE-ENACT 2) on RazumabTM (World's First Biosimilar Ranibizumab) in Retinal Vein Occlusion

Download (122.37 kB)
figure
posted on 2020-06-19, 12:54 authored by Shashikant Sharma, RE-ENACT 2 Study Investigators Group, Mujtaba Khan, Alok Chaturvedi
<p>The above summary slide represents the opinions of the<b> </b>authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).<br></p><p>© The authors, CC-BY-NC 2020</p>

History

Related Materials

  1. 1.
    URL - References https://link.springer.com/article/10.1007/s40123-020-00277-3
  2. 2.
    DOI - Is supplement to A Multicenter, Retrospective Study (RE-ENACT 2) on RazumabTM (World's First Biosimilar Ranibizumab) in Retinal Vein Occlusion

Usage metrics

    Ophthalmology and Therapy

    Categories

    Keywords

    Anti-VEGFBiosimilar ranibizumabRazumabRetinal vein occlusionRVO

    Licence

    CC BY-NC 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC